1. Monash Health
  2. Monash Health research
  3. Monash Health Library Evidence Reports
Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/51595
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAnderson, Alice-
dc.coverage.temporal1946-2023-
dc.date.accessioned2024-04-26T02:38:20Z-
dc.date.available2024-04-26T02:38:20Z-
dc.date.issued2023-03-17-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/51595-
dc.description.abstractThis evidence report summaries the literature on the dose conversion factor of idarubicin and mitozantrone when calculating maximum lifetime cumulative doses of anthracyclines.-
dc.titleLibrary evidence report: Idarubicin and mitozantrone and cumulative lifetime doses of anthracyclines.-
dc.typeEvidence report-
dcterms.audienceThis evidence report is only intended for use by Monash Health employees and researchers.-
dc.identifier.affiliationLibrary Services-
dc.description.databasesOvid MEDLINE-
dc.description.databasesOvid Embase-
item.cerifentitytypePublications-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
item.openairetypeEvidence report-
crisitem.author.deptLibrary Services-
Appears in Collections:Monash Health Library Evidence Reports
Files in This Item:
File Description SizeFormat 
What is the dose conversion factor of idarubicin and mitozantrone - Literature Summary - 20230318_watermark (1)_organized.pdf906.46 kBAdobe PDFView/Open
Show simple item record

Page view(s)

60
checked on Jan 30, 2025

Download(s)

4
checked on Jan 30, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.